GlobeNewswire
-
Frishantic Launches Berberine Supplement with Ceylon Cinnamon for Daily Wellness Routines
20/08/2026 -
Jushi Holdings Inc. Announces Opening of Relocated Beyond Hello™ Dispensary in Belle Vernon, Pennsylvania
20/08/2026 -
Alignment Healthcare to Present in Baird 2026 Global Healthcare Conference and Attend Morgan Stanley 24th Annual Global Healthcare Conference
20/08/2026 -
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
20/08/2026 -
Adagene to Participate in Three Upcoming Investor Conferences
20/08/2026 -
VarmX enrols first participant in global Phase 3 EquilibriX-S trial evaluating VMX C001 in urgent surgery
20/08/2026 -
Evaxion announces business update and second quarter 2026 financial results
20/08/2026 -
InflaRx Announces Participation in September Investor Conferences
20/08/2026 -
Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines
20/08/2026 -
Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
20/08/2026 -
Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates
20/08/2026 -
Herantis Pharma releases 1H 2026 report today
20/08/2026 -
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement
20/08/2026 -
BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026
20/08/2026 -
BioPorto announces Interim Results for the Second Quarter and First half of 2026
20/08/2026 -
Vistin Pharma ASA: Second quarter and YTD 2026 financial results
20/08/2026 -
ALK appoints Jacob Glenting as head of Global R&D
20/08/2026 -
Six-month interim report (Q2) 2026 (unaudited)
20/08/2026 -
Zelluna ASA: Second Quarter 2026 results
20/08/2026
Pages